Pharma Equity Group A/S: Financial statements 2025
CVR: 26791413
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000. The solvency ratio was 65.5%. The company had 5 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Equity
- DKK 25,472,000
- Total Assets
- DKK 38,898,000
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | 0 | - | 25.5 mio. | 5 |
| 2024 | 0 | 0 | -24.4 mio. | 48.9 mio. | - |
| 2023 | 0 | 0 | -24.6 mio. | 38.9 mio. | - |
| 2022 | - | - | 3.5 mio. | 46 mio. | - |
| 2021 | - | - | 5.4 mio. | 42.6 mio. | - |
Official annual report
How creditworthy is Pharma Equity Group A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Equity Group A/S has published its interim report for the period January 1, 2025 – June 30, 2025.
As of August 12, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Pharma Equity Group A/S.
As of August 12, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -24,422,000.
As of April 16, 2025, Troels Peter Troelsen has joined the board of directors of Pharma Equity Group A/S.
As of April 16, 2025, Charlotte Pahl has joined the board of directors of Pharma Equity Group A/S.
As of April 1, 2025, Christian Henrik Tange is registered as adm. dir. of Pharma Equity Group A/S.
As of April 1, 2025, Thomas Kaas Selsø has stepped down as adm. dir. of Pharma Equity Group A/S.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.